NCT00506142
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma treatment 2 completed NCT01773655
Clinical and Histopathologic Characteristics of BAP1 Mutations No drug interventions Not Available Not Available completed NCT04283890
PHP and Immunotherapy in Metastasized UM treatment 1 / 2 recruiting NCT04335890
IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma No drug interventions treatment 1 unknown_status NCT05047276
Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma No drug interventions treatment 1 / 2 not_yet_recruiting NCT05987332
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma treatment 2 / 3 recruiting NCT06581406
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma treatment 2 / 3 not_yet_recruiting NCT00986661
A Study to Assess PV-10 Chemoablation of Cancer of the Liver treatment 1 active_not_recruiting NCT05075993
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors treatment 1 recruiting NCT01551459
A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma treatment 2 completed NCT04879017
FHD-286 in Subjects With Metastatic Uveal Melanoma No drug interventions treatment 1 terminated NCT05170334
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma treatment 2 recruiting NCT02697630
Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye treatment 2 completed NCT05677373
Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma treatment 1 / 2 withdrawn NCT01585194
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma treatment 2 completed NCT04118062
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) No drug interventions other Not Available active_not_recruiting NCT06121180
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma treatment 2 recruiting NCT05282901
Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) treatment 2 recruiting NCT05415072
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas No drug interventions treatment 1 / 2 recruiting NCT01814046
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma treatment 2 terminated NCT04552223
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma treatment 2 active_not_recruiting NCT02831933
Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma treatment 2 terminated NCT04728633
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases treatment 2 recruiting NCT03025256
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease treatment 1 active_not_recruiting NCT03947385
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions treatment 1 / 2 recruiting NCT01587352
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye treatment 2 active_not_recruiting NCT04812470
Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases treatment 1 recruiting NCT01328106
Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma treatment 2 withdrawn NCT04720417
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma treatment 2 active_not_recruiting NCT03068624
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma treatment 1 active_not_recruiting NCT03472586
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver treatment 2 active_not_recruiting NCT05022901
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma treatment 3 active_not_recruiting NCT03865212
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma treatment 1 active_not_recruiting NCT05607095
Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma treatment 1 recruiting